{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:48:01Z","timestamp":1790416081383,"version":"4.1.0"},"reference-count":22,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,12,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To ascertain the genetic basis of pediatric Burkitt lymphoma (pBL), we performed clinical-grade next-generation sequencing of 182 cancer-related genes on 29 formalin-fixed, paraffin embedded primary pBL samples. Ninety percent of cases had at least one mutation or genetic alteration, most commonly involving MYC and TP53. EBV(\u2212) cases were more likely than EBV(+) cases to have multiple mutations (P &lt; .0001). Alterations in tumor-related genes not previously described in BL were identified. Truncating mutations in ARID1A, a member of the SWI\/SNF nucleosome remodeling complex, were seen in 17% of cases. MCL1 pathway alterations were found in 22% of cases and confirmed in an expanded panel. Other clinically relevant genomic alterations were found in 20% of cases. Our data suggest the roles of MCL1 and ARID1A in BL pathogenesis and demonstrate that comprehensive genomic profiling may identify additional treatment options in refractory disease.<\/jats:p>","DOI":"10.1182\/blood-2012-06-437624","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T05:11:57Z","timestamp":1350969117000},"page":"5181-5184","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":100,"title":["Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes"],"prefix":"10.1182","volume":"120","author":[{"given":"Lisa","family":"Giulino-Roth","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Department of Pediatrics, Division of Pediatric Hematology and Oncology, Weill Cornell Medical College, New York, NY;"},{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Foundation Medicine, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa Y.","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Mathew","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Tam","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen T.","family":"Cronin","sequence":"additional","affiliation":[{"name":"Foundation Medicine, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Palmer","sequence":"additional","affiliation":[{"name":"Foundation Medicine, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Lucena-Silva","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Institute of Integrative Medicine Prof Fernando Figueira (IMIP), Recife, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Pedrosa","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Institute of Integrative Medicine Prof Fernando Figueira (IMIP), Recife, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Pedrosa","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Institute of Integrative Medicine Prof Fernando Figueira (IMIP), Recife, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Teruya-Feldstein","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Division of Hematopathology, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bachir","family":"Alobeid","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Division of Hematopathology, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Leoncini","sequence":"additional","affiliation":[{"name":"Department of Human Pathology and Oncology, University of Siena, Siena, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Bellan","sequence":"additional","affiliation":[{"name":"Department of Human Pathology and Oncology, University of Siena, Siena, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rogena","sequence":"additional","affiliation":[{"name":"University of Nairobi, Nairobi, Kenya;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerice A.","family":"Pinkney","sequence":"additional","affiliation":[{"name":"Depatrment of Pediatrics, Division of Pediatric Hematology\/Oncology, Columbia University Medical Center, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Rubin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul C.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"International Outreach Program and Department of Oncology, St Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Yelensky","sequence":"additional","affiliation":[{"name":"Foundation Medicine, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Tam","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Stephens","sequence":"additional","affiliation":[{"name":"Foundation Medicine, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethel","family":"Cesarman","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2019111811175884400_B1","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","article-title":"Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.","volume":"109","author":"Cairo","year":"2007","journal-title":"Blood"},{"issue":"7","key":"2019111811175884400_B2","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","article-title":"Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.","volume":"109","author":"Patte","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2019111811175884400_B3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.leu.2402402","article-title":"Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate (\u2018Orange\u2019) in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report.","volume":"16","author":"Cairo","year":"2002","journal-title":"Leukemia"},{"issue":"7418","key":"2019111811175884400_B4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"1","key":"2019111811175884400_B5","first-page":"26","article-title":"Cytogenetic studies in 30 patients with Burkitt's lymphoma or L3 acute lymphoblastic leukemia with special reference to additional chromosome abnormalities.","volume":"32","author":"Lai","year":"1989","journal-title":"Ann Genet"},{"issue":"3","key":"2019111811175884400_B6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00043426-200403000-00006","article-title":"Chromosome abnormalities may correlate with prognosis in Burkitt\/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08.","volume":"26","author":"Lones","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"2019111811175884400_B7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2141.2009.07967.x","article-title":"An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961.","volume":"148","author":"Nelson","year":"2010","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111811175884400_B8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/cncr.22089","article-title":"Secondary chromosomal abnormalities predict outcome in pediatric and adult high-stage Burkitt lymphoma.","volume":"107","author":"Onciu","year":"2006","journal-title":"Cancer"},{"issue":"6","key":"2019111811175884400_B9","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1182\/blood.V95.6.2104","article-title":"c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover.","volume":"95","author":"Bahram","year":"2000","journal-title":"Blood"},{"issue":"7","key":"2019111811175884400_B10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc3068","article-title":"SWI\/SNF nucleosome remodellers and cancer.","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"2019111811175884400_B11","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas.","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111811175884400_B12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/ng.2246","article-title":"Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.","volume":"44","author":"Zang","year":"2012","journal-title":"Nat Genet"},{"issue":"12","key":"2019111811175884400_B13","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ng.982","article-title":"Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.","volume":"43","author":"Wang","year":"2011","journal-title":"Nat Genet"},{"issue":"1","key":"2019111811175884400_B14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death.","volume":"9","author":"Youle","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"2019111811175884400_B15","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1182\/blood.V97.12.3902","article-title":"MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes.","volume":"97","author":"Zhou","year":"2001","journal-title":"Blood"},{"issue":"9","key":"2019111811175884400_B16","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/blood.V92.9.3226.421k49_3226_3239","article-title":"Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage.","volume":"92","author":"Zhou","year":"1998","journal-title":"Blood"},{"issue":"4","key":"2019111811175884400_B17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2141.2011.08883.x","article-title":"Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression.","volume":"155","author":"Schiffman","year":"2011","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111811175884400_B18","first-page":"892","article-title":"An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine.","volume":"62","author":"Vrana","year":"2002","journal-title":"Cancer Res"},{"issue":"7336","key":"2019111811175884400_B19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature09779","article-title":"Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.","volume":"471","author":"Wertz","year":"2011","journal-title":"Nature"},{"issue":"1","key":"2019111811175884400_B20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1517\/14728214.2010.515210","article-title":"Emerging Bcl-2 inhibitors for the treatment of cancer.","volume":"16","author":"Azmi","year":"2011","journal-title":"Expert Opin Emerg Drugs"},{"issue":"7336","key":"2019111811175884400_B21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature09732","article-title":"SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.","volume":"471","author":"Inuzuka","year":"2011","journal-title":"Nature"},{"key":"2019111811175884400_B22","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer.","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/26\/5181\/1361116\/zh805212005181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/26\/5181\/1361116\/zh805212005181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T16:30:28Z","timestamp":1574094628000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/26\/5181\/30917\/Targeted-genomic-sequencing-of-pediatric-Burkitt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,20]]},"references-count":22,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2012,12,20]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-06-437624","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,20]]}}}